Prostate laser therapy treatment could save NHS £3m, says NICE

The NHS has been advised to implement a specialised laser treatment to manage symptoms that occur as a result of an enlarged prostate, which has been predicted to save the NHS £3 million.

If the proposal is accepted, around 13,000 men in England could benefit from the new treatment, with the National Institute for Health and Care Excellence (NICE) saying that such patients could have the new therapy in place of conventional surgery.

The laser therapy works by delivering a beam of green light to vaporise excess tissue and is less invasive than the currently used procedure which involves cutting away the tissue using a heated loop of wire.

The incidence of men suffering with an enlarged prostate (also known as benign prostatic hyperplasia) is very common and increases with age. However, if left untreated it can interfere with the functioning of the bladder, causing difficultly passing urine.

Professor Carole Longson, from the NICE, said: "Whilst benign enlarged prostates may not be life-threatening, the condition can impact on men's lives significantly.

"A procedure to reduce the amount of excess prostate tissue can improve the quality of life for men."

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho